ADVERTISEMENT
Line drawings of Moungi Bawendi (left), Louis Brus (center), and Alexei Ekimov (right) from the shoulders up.
Nobel Prize in Chemistry for Quantum Dots
Moungi Bawendi, Louis Brus, and Alexei Ekimov were awarded the Nobel Prize for their work on quantum dots, which has applications in electronics and biomedicine.
Nobel Prize in Chemistry for Quantum Dots
Nobel Prize in Chemistry for Quantum Dots

Moungi Bawendi, Louis Brus, and Alexei Ekimov were awarded the Nobel Prize for their work on quantum dots, which has applications in electronics and biomedicine.

Moungi Bawendi, Louis Brus, and Alexei Ekimov were awarded the Nobel Prize for their work on quantum dots, which has applications in electronics and biomedicine.

diagnostics

Erkin Kuru (left) and Helena de Puig (right).
Lighting Up Diagnostics
Danielle Gerhard, PhD | Sep 8, 2023 | 6 min read
Brought together by a shared interest in synthetic biology and diagnostics, two researchers are transforming how we label biomolecules.
Illustration showing how this new novel nanotechnology simultaneously ‘fishes’ for multiple viruses or viral variants using different DNA nanobait that are designed to target specific viral sequences.
Fishing for Viruses With DNA Nanobait
Danielle Gerhard, PhD | Sep 1, 2023 | 2 min read
Scientists developed a novel nanotechnology that simultaneously detects multiple viruses from patient samples in less than an hour.
Learn how recombinant proteins move the diagnostic industry forward
Emergent Recombinant Proteins in Clinical Diagnostics
Scripps Laboratories | 1 min read
A new era of reliable recombinant proteins makes it possible for researchers to replace tissue-derived biomarkers in a variety of diagnostic assays.
A vet and technician take a sample from a dog for use in PetDx’s OncoK9 test, which screens cell-free DNA for genomic alterations associated with cancer.
The Pet Health Industry Takes on Canine Cancer
Diana Kwon | Oct 17, 2022 | 9 min read
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
an artistic rendering of CRISPR/Cas9
Ten Years of CRISPR
Sophie Fessl, PhD | Jun 28, 2022 | 7 min read
This month marks ten years since CRISPR-Cas9 was repurposed as a gene editing system, so we’re looking back at what has been accomplished in a decade of CRISPR editing.
Learn How Multiomics Drives Biotherapeutic Discovery and Development
Advancing Biotherapeutics with Multiomics
The Scientist’s Creative Services Team and Tecan | 1 min read
Explore how biomolecular processes drive health and disease.
Tumor microbiome composite
Could Cancer’s Microbiome Help Diagnose and Treat the Disease?
Jef Akst | Mar 14, 2022 | 10+ min read
A growing appreciation of the bacterial assemblages that live within tumors has researchers striving to understand and capitalize on their role.
Illustration showing microbial signatures of cancer in the body
Infographic: Putting Cancer’s Unique Microbiomes to Use
Jef Akst | Mar 14, 2022 | 1 min read
From diagnosis to tracking treatment responses, bacteria and other microbes in the blood, gut, and tumors of cancer patients may provide helpful hints for improving their care.
Why Automation Is a Necessity for Clinical Diagnostics
Bringing Fluency to Clinical Diagnostics Through Automation 
Tecan | 1 min read
Automated liquid handling workstations offer flexibility for a wide range of application and process needs.
Rapid antigen tests for SARS-CoV-2
Are Rapid Tests Worse at Detecting Omicron—and Does It Matter?
Catherine Offord | Jan 14, 2022 | 10 min read
Anecdotal reports and results from small studies on the diagnostics’ accuracy have prompted questions about the devices’ usage with the new variant, but researchers say more data are needed and emphasize the continued importance of SARS-CoV-2 testing.
A Theranos sign outside the company's headquarters
Theranos Founder Elizabeth Holmes Convicted of Fraud
Amanda Heidt | Jan 4, 2022 | 4 min read
After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.
Discover How to Design Sensitive Nucleic Acid Lateral Flow Assays
Go with the Flow: Adapting Lateral Flow Assays for Nucleic Acid Detection
The Scientist’s Creative Services Team and nanoComposix | 1 min read
Scientists incorporate sensitive nanoparticles to rapidly detect DNA and RNA.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist Staff | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
orange and blue cell image
Woman’s Body Appears to Rid Itself of HIV
Chloe Tenn | Nov 18, 2021 | 3 min read
Researchers report what appears to be the second case of a person’s immune system clearing the virus on its own.
Improve qPCR Efficiency and Reproducibility
The Components of Effective qPCR
The Scientist’s Creative Services Team and Bio-Rad Laboratories | 1 min read
Putting the pieces together for molecular diagnostics and infectious disease research
800x800
A 3-D Tumor Microenvironment for Personalized Immunotherapy
Roni Dengler, PhD | Sep 10, 2021 | 2 min read
A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time.
800x560-misherlock-0916
A New COVID-19 Spit Test Is as Easy as 1-2-3
Roni Dengler, PhD | Aug 16, 2021 | 4 min read
A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.
gold nanoshells
Getting More Lateral Flow Test Sensitivity with Nanoshell Probes
The Scientist’s Creative Services Team and nanoComposix | 3 min read
Silica-gold nanoshells highlight how good probe design can boost assay performance.
photograph of miSHERLOCk device against a white background
A Self-Contained COVID-19 Test with 3-D Printed Parts
Annie Melchor | Aug 11, 2021 | 7 min read
The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.
ADVERTISEMENT